- Home
- ANAB vs CNOB Comparison
ANAB vs CNOB Comparison
Compare ANAB & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANAB | CNOB |
|---|---|---|
| Founded | 2005 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANAB | CNOB |
|---|---|---|
| Price | $62.02 | $27.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $74.64 | $30.33 |
| AVG Volume (30 Days) | ★ 601.6K | 332.5K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ 91.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $234,603,000.00 | N/A |
| Revenue This Year | N/A | $42.85 |
| Revenue Next Year | $31.11 | $7.27 |
| P/E Ratio | ★ N/A | $17.02 |
| Revenue Growth | ★ 157.01 | N/A |
| 52 Week Low | $15.40 | $20.61 |
| 52 Week High | $68.39 | $29.28 |
Technical Indicators
Market Signals| Indicator | ANAB | CNOB |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 61.19 |
| Support Level | $43.67 | $25.88 |
| Resistance Level | $67.69 | $28.50 |
| Average True Range (ATR) | 4.07 | 0.64 |
| MACD | -0.57 | 0.19 |
| Stochastic Oscillator | 60.16 | 100.00 |
Price Performance
Historical ComparisonAbout ANAB AnaptysBio Inc.
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.